Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children
This study has been completed.
Study NCT01125527   Information provided by Novartis

First Received on May 14, 2010.   Last Updated on December 27, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Diphtheria
Influenza, Human
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Corynebacterium Infections
Gram-Positive Bacterial Infections
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Additional drug interventions recognized in this trial
Krestin
More general drug interventions related to this trial
Adjuvants, Immunologic
Anti-Infective Agents
Antibiotics, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Immunologic Factors
Interferon Inducers
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Novartis Vaccines


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services